Patent · US Active

Beta lactams as modulators of glutamate uptake and methods for use thereof

US10759750B2 · kind B2 · utility

0Cited by
3References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 27, 2017
Grant dateSep 1, 2020
Priority date
Expiry dateApr 27, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/10
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Pharmaceutical compositions of the invention comprise compounds, compositions, methods useful for the treatment of drug addiction, drug withdrawal, and diseases or conditions that involve dysregulation of glutamate homeostasis in its etiology.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.